ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

brivaracetam

Also written as “Brivaracetam”, “Brivaracetam Film-coated tablet” and “Brivaracetam oral solution”.

Its studies are mostly in Epilepsy · Epilepsy, Absence · Epilepsies, Partial · Myoclonus · Seizures, led by 4 companies.

Drug pageBrivaracetam: every studyAll 48 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 3, since Sep 6, 200542 company-led studies, 3 open or runningNext primary completion: Nov 16, 2029 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
UCBits history only392 open or runningphase 3since Sep 6, 2005Sep 6, 2005Nov 16, 2029phase 3 · NCT06315322
Overseas Pharmaceuticals10 open or runningphase 1since Nov 11, 2022Nov 11, 2022none ahead
Qingfeng Pharmaceutical Groupits history only10 open or runningphase 3since Apr 17, 2026Apr 17, 2026none ahead
Sino Biopharmaceuticalits history only11 open or runningphase 1since Dec 23, 2024Dec 23, 2024none ahead

Also a collaborator on its studies: PRA Health Sciences.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Overseas Pharmaceuticals only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Nov 11, 2022First study: phase 1 study in SeizuresFirst studyNCT05622370 · 12 enrolled · China

TargetBeta

SV2A →read by rule
“Synaptic vesicle glycoprotein 2A modulator”ChEMBL 37, by rule

Other programs on SV2A

ProgramCompanyFurthest phaseStudies
LevetiracetamruleUCBphase 473

Studies

The one study Overseas Pharmaceuticals leads. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT05622370Seizures · China1UNKNOWNMar 30, 202312

How it is read

Names in the registry

  • “Brivaracetam”, 33 entries
  • “brivaracetam”, 3 entries
  • “Brivaracetam Film-coated tablet”, 2 entries
  • “Brivaracetam oral solution”, 2 entries
  • “Brivaracetam 25 mg”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.